EUVIMEDEUVIMED entdecken
Open Access

HNRNPH1 stabilizes FLOT2 mRNA in a non-canonical m6A-dependent manner to promote malignant progression in nasopharyngeal carcinoma

Qiguang Li, Jie Liu, Chong Zeng, Daogang Qin, Zijian Zhang, Qiaoli Lv, Jingao Li, Wei Huang

Cellular Oncology · 2024

DOI: 10.1007/s13402-024-01016-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, 2024. Verfasst von Qiguang Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Shandong Provincial Hospital, Shandong First Medical University, Jinan, China. Hauptthemen laut MEDLINE: Nasopharyngeal Carcinoma, RNA Stability, RNA, Messenger, Disease Progression. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Natural Science Foundation of Hunan Province of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nasopharyngeal CarcinomaRNA StabilityRNA, MessengerDisease ProgressionNasopharyngeal NeoplasmsGene Expression Regulation, NeoplasticMethyltransferasesCell ProliferationHumansCell Line, TumorMaleFemaleMice, NudeAnimalsMembrane ProteinsHeterogeneous Nuclear Ribonucleoprotein D0Middle AgedAdenosineMice, Inbred BALB CMice

Stichwörter der Autor:innen

FLOT2HNRNPH1METTL14N6-methyladenosine (m6A) modificationNasopharyngeal carcinoma

Substanzen

RNA, MessengerMethyltransferasesMETTL14 protein, humanMembrane ProteinsHeterogeneous Nuclear Ribonucleoprotein D0N-methyladenosineAdenosine

Autor:innen und Institutionen

  • Department of Oncology, Shandong Provincial Hospital, Shandong First Medical University, Jinan, China.
  • Department of Pathology, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, China.
  • Department of Respiratory and critical care medicine, The Seventh Affiliated Hospital, Hengyang Medical School, University of South China, Changsha, China.
  • School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • Department of Radiation Oncology, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • National Clinical Research Center of Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province
  • Natural Science Foundation of Hunan Province of China
  • Health Research Project of Hunan Provincial Health Commission
  • Distinguished Young Scholars program of the Natural Science Foundation of Jiangxi Province
  • Science and Technology Research Project of Jiangxi Provincial Department of Education
  • Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences
  • Open Fund for Scientific Research of NHC Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma

Zitieren

APA

Li, Q., Liu, J., Zeng, C., Qin, D., Zhang, Z., Lv, Q., Li, J., & Huang, W. (2024). HNRNPH1 stabilizes FLOT2 mRNA in a non-canonical m6A-dependent manner to promote malignant progression in nasopharyngeal carcinoma. Cellular Oncology. https://doi.org/10.1007/s13402-024-01016-7

Vancouver

Li Q, Liu J, Zeng C, Qin D, Zhang Z, Lv Q, et al. HNRNPH1 stabilizes FLOT2 mRNA in a non-canonical m6A-dependent manner to promote malignant progression in nasopharyngeal carcinoma. Cellular Oncology. 2024. doi:10.1007/s13402-024-01016-7

BibTeX
@article{Li2024,
  author = {Li, Qiguang and Liu, Jie and Zeng, Chong and Qin, Daogang and Zhang, Zijian and Lv, Qiaoli and Li, Jingao and Huang, Wei},
  title = {HNRNPH1 stabilizes FLOT2 mRNA in a non-canonical m6A-dependent manner to promote malignant progression in nasopharyngeal carcinoma},
  journal = {Cellular Oncology},
  year = {2024},
  doi = {10.1007/s13402-024-01016-7}
}
Kostenlos starten →